Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer

BACKGROUND: The recently developed reagent, eribulin mesylate (eribulin), is a microtubule dynamics inhibitor with a mechanism of action that differs from those of taxanes and vinca alkaloids. This drug is considered to be a promising chemotherapeutic agent for the treatment of locally advanced or m...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Cancer
Glavni autori: Kashiwagi, Shinichiro, Fukushima, Wakaba, Asano, Yuka, Goto, Wataru, Takada, Koji, Noda, Satoru, Takashima, Tsutomu, Onoda, Naoyoshi, Ohsawa, Masahiko, Hirakawa, Kosei, Ohira, Masaichi
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5580315/
https://ncbi.nlm.nih.gov/pubmed/28859615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3598-5
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items